Dare Bioscience DARE
NASDAQ DARE
$0.68 -0.01 (-1.26%)
As of: Oct 21, 2026 · 3:49 PM EDT

Dare Bioscience (DARE) Current Leases (2025 - 2026)

Updated

Dare Bioscience's Current Leases was $149,374 in Q2 2026, down 91.8% from $1.83 million a year earlier.

Analysis

Dare Bioscience (DARE) Current Leases (2025 - 2026) Analysis & Trends

At the end of FY2025, Current Leases at Dare Bioscience came in at $1.49 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Dare Bioscience 10.13 Mn -55.33 Mn -132,343.00 149,374.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 149,374.00
Dec 31, 2025 1.49 Mn
Sep 30, 2025 1.87 Mn
Jun 30, 2025 1.83 Mn
Mar 31, 2025 1.75 Mn
API Access

Dare Bioscience Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=DARE&period=max&api_key=YOUR_API_KEY